These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17194825)

  • 1. Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice.
    Lewis RE; Chamilos G; Prince RA; Kontoyiannis DP
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1078-81. PubMed ID: 17194825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of high doses of liposomal amphotericin B in the treatment of experimental aspergillosis.
    Martín MT; Gavaldà J; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Jordano Q; Ruiz I; Rosal M; Almirante B; Pahissa A
    J Antimicrob Chemother; 2003 Dec; 52(6):1032-4. PubMed ID: 14613950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA.
    Godet C; Meurice JC; Roblot F; Kauffmann-Lacroix C; Verdaguer M; Frat JP; Cadranel J
    Eur Respir J; 2012 May; 39(5):1261-3. PubMed ID: 22547734
    [No Abstract]   [Full Text] [Related]  

  • 4. Liposomal Amphotericin B Fosters the Corticosteroids' Anti-inflammatory Effect on Murine Allergic Bronchopulmonary Aspergillosis Model Airways.
    Fukushima C; Matsuse H; Obase Y; Fukahori S; Tsuchida T; Kawano T; Kohno S; Mukae H
    Inflammation; 2019 Dec; 42(6):2065-2071. PubMed ID: 31396817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel inhalational murine model of invasive pulmonary aspergillosis.
    Sheppard DC; Rieg G; Chiang LY; Filler SG; Edwards JE; Ibrahim AS
    Antimicrob Agents Chemother; 2004 May; 48(5):1908-11. PubMed ID: 15105158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Remission of invasive sinusal and pulmonary aspergillosis with liposomal amphotericin B in a patient with chronic lymphatic leukemia following failure with conventional amphotericin].
    Palacio C; Acebedo G; López A; Jodar JM
    Sangre (Barc); 1994 Oct; 39(5):389-92. PubMed ID: 7754445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of invasive pulmonary aspergillosis in an immunocompetent host.
    Polat G; Urpek G; Yilmaz U; Büyükşirin M; Karadağ Polat S; Uluer S; Tibet G
    Respirology; 2005 Jun; 10(3):393-5. PubMed ID: 15955156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice.
    Khan MA; Nasti TH; Owais M
    J Antimicrob Chemother; 2005 Oct; 56(4):726-31. PubMed ID: 16126780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
    Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats.
    Ullmann AJ; Krammes E; Sommer S; Buschmann I; Jahn-Muehl B; Cacciapuoti A; Schmitt HJ
    J Antimicrob Chemother; 2007 Nov; 60(5):1080-4. PubMed ID: 17855727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy.
    Walsh TJ; Garrett K; Feurerstein E; Girton M; Allende M; Bacher J; Francesconi A; Schaufele R; Pizzo PA
    Antimicrob Agents Chemother; 1995 May; 39(5):1065-9. PubMed ID: 7625790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bronchopulmonary aspergillosis: new developments].
    Germaud P; Renaudin K; Danner I; Morin O; De Lajartre AY
    Rev Mal Respir; 2001 Jun; 18(3):257-66. PubMed ID: 11468587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antifungal efficacy in experimental invasive pulmonary aspergillosis by combination of AmBisome with Fungizone as assessed by several parameters of antifungal response.
    Becker MJ; de Marie S; Fens MH; Hop WC; Verbrugh HA; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2002 May; 49(5):813-20. PubMed ID: 12003976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of inhaled amphotericin in allergic bronchopulmonary aspergillosis.
    Sehgal IS; Agarwal R
    J Postgrad Med; 2014; 60(1):41-5. PubMed ID: 24625938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4.
    Bellocchio S; Gaziano R; Bozza S; Rossi G; Montagnoli C; Perruccio K; Calvitti M; Pitzurra L; Romani L
    J Antimicrob Chemother; 2005 Feb; 55(2):214-22. PubMed ID: 15649994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosolized amphotericin for the treatment of allergic bronchopulmonary aspergillosis.
    Hayes D; Murphy BS; Lynch JE; Feola DJ
    Pediatr Pulmonol; 2010 Nov; 45(11):1145-8. PubMed ID: 20658484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis.
    Becker MJ; de Marie S; Fens MH; Verbrugh HA; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2003 Sep; 52(3):428-34. PubMed ID: 12917249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis.
    Wiederhold NP; Tam VH; Chi J; Prince RA; Kontoyiannis DP; Lewis RE
    Antimicrob Agents Chemother; 2006 Feb; 50(2):469-73. PubMed ID: 16436698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.